No Detail Found!

Molecular identification of Blastocystis hominis isolates in patients with and without Gastrointestinal diseases

Author(s)
Khadiga Ahmed Ismail Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia
Howaida Mahmoud Hagag Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia
Abdulraheem Ali Almalki Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia
Mazen Almehmadi Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia
Hamsa Jameel Banjer Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia
Maha M. Abdulwahab Department of Medical Parasitology, King Faisal Medical Complex,Taif,Saudi Arabia
Mubark Rashid Alyami Director of King Faisal Medical Complex and Obstetrics and Gynecology Tower, Taif, Saudi Arabia
Sahar Ali Qahtani Department of Clinical Laboratory Sciences, in poison control and forensic chemistry centre Jeddah,,Saudi Arabia
Ebtisam Ayidh Alghamdi Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia
Mahmoud K. Marzouq Department of Dermatology and Venereology, King Faisal Medical Complex,Taif,Saudi Arabia
Khwaimsah Mohammad Alsubei Department of Chemistry, King Faisal Medical Complex,Taif,Saudi Arabia
Karim Amr Ramadan Department of Internal Medicine, Kasr Alani Faculty of Medicine, Cairo University,Cairo,Egypt
Osama M. Khalifa Department of Internal Medicine, Faculty of Medicine, Ain Shams University,Cairo,Egypt
Abstract
Blastocystis hominis (B. hominis) is an anaerobic, single-cell protozoan, it is the most common protozoan in human fecal samples with potential pandemic distribution. The prevalence of B. hominis varies. The aim of this study was to detect prevalence of B. hominis in patients complain of gastrointestinal and non-gastrointestinal troubles. A case control study was conducted during the period from January 2022 to April 2023. Stool samples were collected from 100 patients (50 complain of gastrointestinal and 50 without gastrointestinal troubles) and examined by wet mount microscopic examination, stained by trichrome stain and conventional PCR molecular technique were used to confirm the diagnosis. PCR was the gold stander test for diagnosis. Also blood samples were collected for complete blood count. The prevalence of B. hominis in this study was 7/50 (14%) using PCR, in patients complain of gastrointestinal troubles, 5/50 (10%) using PCR, in patients complain of non-gastrointestinal troubles and 12/100 (12%) in total patients under study complain of gastrointestinal and without gastrointestinal troubles. There was increase in prevalence in rural area 5/14 (35.5%) in comparison to urban area 7/86 (8.1%) due to unsanitary living conditions, frequent animal contact, and consumption of tainted water and food. PCR is sensitive and specific test for diagnosis of B. hominis and its prevalence was high especially in patients with gastrointestinal troubles, so it is recommended to implement preventive measures and awareness programs regarding sanitation and personal hygiene.
Publication Details
Page(s) 741-749
DOI DOI not available
Published Journal: Bioscience Research, Volume: 20, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
prevalence, Blastocystis hominis
0

Citations

0

Downloads

60

Views